Literature DB >> 6154900

L-kynurenine: its synthesis and possible regulatory function in brain.

E M Gál, A D Sherman.   

Abstract

One pathway by which tryptophan is metabolized in the brain as well as in the periphery is through cleavage of the indole ring to formylkynurenine and then kynurenine. Indoleamine-2,3-dioxygenase, the enzyme that catalyzes this cleavage, and kynurenine are distributed all across the different anatomic regions of brain. Approximately 40% of the kynurenine in brain is synthesized there, the remainder having come from plasma. Tryptophan loading, which has been used both experimentally and therapeutically as a means of increasing tryptophan conversion to serotonin, also increases kynurenine formation in the brain and in the periphery. Because of the formation of kynurenine, which competes for cerebral transport and cellular uptake of L-tryptophan, and because of substrate inhibition on tryptophan hydroxylase, excessively high doses of tryptophan may actually decrease the production of cerebral serotonin and 5-hydroxyindoleacetic acid.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6154900     DOI: 10.1007/BF00964611

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  36 in total

Review 1.  Control of brain neurotransmitter synthesis by precursor availability and nutritional state.

Authors:  R J Wurtman; J D Fernstrom
Journal:  Biochem Pharmacol       Date:  1976-08-01       Impact factor: 5.858

2.  Inhibition of tryptophan pyrrolase by serotonin, epinephrine and tryptophan analogs.

Authors:  E FRIEDEN; G W WESTMARK; J M SCHOR
Journal:  Arch Biochem Biophys       Date:  1961-01       Impact factor: 4.013

3.  Cerebral tryptophan-2,3-dioxygenase (pyrrolase) and its induction in rat brain.

Authors:  E M Gál
Journal:  J Neurochem       Date:  1974-05       Impact factor: 5.372

4.  Partial purification and characterization of tryptophan hydroxylase from rabbit hindbrain.

Authors:  P A Friedman; A H Kappelman; S Kaufman
Journal:  J Biol Chem       Date:  1972-07-10       Impact factor: 5.157

5.  Kynurenine formamidase. Purification and characterization of the adult chicken liver enzyme and immunochemical analyses of the enzyme of developing chicks.

Authors:  C G Bailey; C Wagner
Journal:  J Biol Chem       Date:  1974-07-25       Impact factor: 5.157

6.  New degradative routes of 5-hydroxytryptophan and serotonin by intestinal tryptophan 2,3-dioxygenase.

Authors:  F Hirata; O Hayaishi
Journal:  Biochem Biophys Res Commun       Date:  1972-06-09       Impact factor: 3.575

7.  Evidence for the synthesis and storage of 5-hydroxytryptamine in two separate pools in the brain.

Authors:  P J Shields; D Eccleston
Journal:  J Neurochem       Date:  1973-03       Impact factor: 5.372

8.  Synthesis and metabolism of L-kynurenine in rat brain.

Authors:  E M Gál; A D Sherman
Journal:  J Neurochem       Date:  1978-03       Impact factor: 5.372

9.  Regional and subcellular changes in the concentration of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the rat brain caused by hydrocortisone, DL- -methyl-tryptophan l-kynurenine and immobilization.

Authors:  G Curzon; A R Green
Journal:  Br J Pharmacol       Date:  1971-09       Impact factor: 8.739

10.  Enzymic formation of D-kynurenine from D-tryptophan.

Authors:  K Higuchi; O Hayaishi
Journal:  Arch Biochem Biophys       Date:  1967-05       Impact factor: 4.013

View more
  71 in total

1.  Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine.

Authors:  Kathleen S Alexander; Hui-Qiu Wu; Robert Schwarcz; John P Bruno
Journal:  Psychopharmacology (Berl)       Date:  2011-10-26       Impact factor: 4.530

2.  Pre- and postnatal exposure to kynurenine causes cognitive deficits in adulthood.

Authors:  Ana Pocivavsek; Hui-Qiu Wu; Greg I Elmer; John P Bruno; Robert Schwarcz
Journal:  Eur J Neurosci       Date:  2012-04-20       Impact factor: 3.386

3.  Kynurenine and Tryptophan Levels in Patients With Schizophrenia and Elevated Antigliadin Immunoglobulin G Antibodies.

Authors:  Olaoluwa Okusaga; Dietmar Fuchs; Gloria Reeves; Ina Giegling; Annette M Hartmann; Bettina Konte; Marion Friedl; Maureen Groer; Thomas B Cook; Kelly A Stearns-Yoder; Janardan P Pandey; Deanna L Kelly; Andrew J Hoisington; Christopher A Lowry; William W Eaton; Lisa A Brenner; Dan Rujescu; Teodor T Postolache
Journal:  Psychosom Med       Date:  2016-10       Impact factor: 4.312

4.  Kynurenine is correlated with IL-1β in plasma of schizophrenia patients.

Authors:  Helena P G Joaquim; Alana C Costa; Wagner F Gattaz; Leda Leme Talib
Journal:  J Neural Transm (Vienna)       Date:  2018-01-06       Impact factor: 3.575

5.  Inhibition of Large Neutral Amino Acid Transporters Suppresses Kynurenic Acid Production Via Inhibition of Kynurenine Uptake in Rodent Brain.

Authors:  Airi Sekine; Yusuke Kuroki; Tomomi Urata; Noriyuki Mori; Tsutomu Fukuwatari
Journal:  Neurochem Res       Date:  2016-05-09       Impact factor: 3.996

6.  Maternal Inflammation Results in Altered Tryptophan Metabolism in Rabbit Placenta and Fetal Brain.

Authors:  Monica Williams; Zhi Zhang; Elizabeth Nance; Julia L Drewes; Wojciech G Lesniak; Sarabdeep Singh; Diane C Chugani; Kannan Rangaramanujam; David R Graham; Sujatha Kannan
Journal:  Dev Neurosci       Date:  2017-05-11       Impact factor: 2.984

Review 7.  Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis.

Authors:  Eric Plitman; Yusuke Iwata; Fernando Caravaggio; Shinichiro Nakajima; Jun Ku Chung; Philip Gerretsen; Julia Kim; Hiroyoshi Takeuchi; M Mallar Chakravarty; Gary Remington; Ariel Graff-Guerrero
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

8.  Activation of the Serotonin Pathway is Associated with Poor Outcome in COPD Exacerbation: Results of a Long-Term Cohort Study.

Authors:  Marc A Meier; Manuel Ottiger; Alaadin Vögeli; Christian Steuer; Luca Bernasconi; Robert Thomann; Mirjam Christ-Crain; Christoph Henzen; Claus Hoess; Werner Zimmerli; Andreas Huber; Beat Mueller; Philipp Schuetz
Journal:  Lung       Date:  2017-04-22       Impact factor: 2.584

9.  Branched-chain amino acids alter neurobehavioral function in rats.

Authors:  Anna Coppola; Brett R Wenner; Olga Ilkayeva; Robert D Stevens; Mauro Maggioni; Theodore A Slotkin; Edward D Levin; Christopher B Newgard
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-12-18       Impact factor: 4.310

10.  Cardiovascular actions of kynuramine and 5-hydroxykynuramine in pithed rats.

Authors:  K G Charlton; T D Johnson; A T Hamed; D E Clarke
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.